# METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
> **ANDA208535** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS USA INC · Approved 2026-06-30
## Drug
- **FDA Application Number:** ANDA208535
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
- **Generic name:** Metformin Hydrochloride
- **Active ingredients:** METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ZYDUS PHARMS USA INC
- **First approval:** 2026-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208535)
---
*MORVS · CC0 1.0*